By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics today announced an exclusive agreement with DPC Lebanon for the distribution of the Epi proColon colorectal cancer test in parts of the Middle East.

Under the agreement, DPC Lebanon will distribute the test for the early detection of colorectal cancer in blood in Lebanon, the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Syria, Jordan, and Egypt.

Financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.